An experimental protocol for in situ colorectal liver metastases ablation by radiofrequency toward a standard procedure

Background: Radiofrequency ablation (RF) is already a viable alternative to surgical resection for focal liver tumors treatment. The use of RF ablation in combination with surgery or chemotherapy and the large panel of RF tools need new experimental models to develop new opportunities for this kind...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cancer research and therapeutics 2019-01, Vol.15 (1), p.164-168
Hauptverfasser: Gonganau-Nitu, Daniel, Scurtu, Radu, Precup, Calin, Ciuce, Constantin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 168
container_issue 1
container_start_page 164
container_title Journal of cancer research and therapeutics
container_volume 15
creator Gonganau-Nitu, Daniel
Scurtu, Radu
Precup, Calin
Ciuce, Constantin
description Background: Radiofrequency ablation (RF) is already a viable alternative to surgical resection for focal liver tumors treatment. The use of RF ablation in combination with surgery or chemotherapy and the large panel of RF tools need new experimental models to develop new opportunities for this kind of therapy. Purpose: The purpose of this study was to identify the optimal RF parameters that will allow in situ colic cancer liver metastases destruction with minimal secondary effects. Materials and Methods: The CC531s colic cancer tumor cells were used to induce liver metastases in 30 synergic Wag/Rij rats. When metastases reached at least 1 cm in diameter, RF generator RITA 1500X, and expandable tip RF probe Starburst SDE (Angiodynamics, USA) was used for the RF ablation. The animal survival rate and the RF-induced lesions have been studied, while only the generator delivered power has been modified (90W, 20W, and 10W, respectively). Results: Survival was significantly low in the group with 90W-delivered power RF. Moreover, statistically significant differences were revealed between groups with high and low RF power, regarding the morphological changes of the liver parenchyma and the adjacent organs, without significant difference on the RF therapeutically effect. Conclusions: In an experimental setting, an increased RF generator power induces important lesions of the abdominal organs with subsequently important mortality rate, without improving the RF therapeutic efficiency.
doi_str_mv 10.4103/jcrt.JCRT_344_17
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2193621508</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A578873911</galeid><sourcerecordid>A578873911</sourcerecordid><originalsourceid>FETCH-LOGICAL-c536e-6ee858c52e064517925ce7be9c7295408cd3729aa1ebcff7ea8d6d8711ccde673</originalsourceid><addsrcrecordid>eNp1ks2P1CAYxonRuOPq3ZMh8eKlI5S20ONksq6aTUzMeiYU3m46S2EEunX-e-nOrl8ZAwkv8HseIDwIvaZkXVHC3u90SOvP26_XklWVpPwJWtG2FUVFmXiKVqTlrKCVKM_Qixh3hNS8LMVzdMaIEITzaoXmjcPwYw9hGMElZfE--OS1t7j3AQ8OxyFNOM99AL3s2-EOAh4hqZg7RKw6q9LgHe4OOCgz-D7A9wmcPuDkZxUMVjijzixldtdgpgAv0bNe2QivHsZz9O3DxfX2Y3H15fLTdnNV6Jo1UDQAoha6LoE0VU15W9YaeAet5mVbV0Row3KlFIVO9z0HJUxjBKdUawMNZ-fo3dE3n5xvFZMch6jBWuXAT1GWtGVNSWsiMvr2H3Tnp-Dy7e4pStpasN_UjbIgB9f7FJReTOWm5kJw1lKaqeIEdQMOgrLeQT_k5b_49Qk-NwPjoE8KyFGgg48xQC_3-QtVOEhK5JINuWRD_pGNLHnz8L6pG8H8EjyGIQMXR2D2NkGIt3aaIcjM3jo__9dY0qaSGycfY8R-AvmAzz4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2193109583</pqid></control><display><type>article</type><title>An experimental protocol for in situ colorectal liver metastases ablation by radiofrequency toward a standard procedure</title><source>MEDLINE</source><source>Medknow Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Gonganau-Nitu, Daniel ; Scurtu, Radu ; Precup, Calin ; Ciuce, Constantin</creator><creatorcontrib>Gonganau-Nitu, Daniel ; Scurtu, Radu ; Precup, Calin ; Ciuce, Constantin</creatorcontrib><description>Background: Radiofrequency ablation (RF) is already a viable alternative to surgical resection for focal liver tumors treatment. The use of RF ablation in combination with surgery or chemotherapy and the large panel of RF tools need new experimental models to develop new opportunities for this kind of therapy. Purpose: The purpose of this study was to identify the optimal RF parameters that will allow in situ colic cancer liver metastases destruction with minimal secondary effects. Materials and Methods: The CC531s colic cancer tumor cells were used to induce liver metastases in 30 synergic Wag/Rij rats. When metastases reached at least 1 cm in diameter, RF generator RITA 1500X, and expandable tip RF probe Starburst SDE (Angiodynamics, USA) was used for the RF ablation. The animal survival rate and the RF-induced lesions have been studied, while only the generator delivered power has been modified (90W, 20W, and 10W, respectively). Results: Survival was significantly low in the group with 90W-delivered power RF. Moreover, statistically significant differences were revealed between groups with high and low RF power, regarding the morphological changes of the liver parenchyma and the adjacent organs, without significant difference on the RF therapeutically effect. Conclusions: In an experimental setting, an increased RF generator power induces important lesions of the abdominal organs with subsequently important mortality rate, without improving the RF therapeutic efficiency.</description><identifier>ISSN: 0973-1482</identifier><identifier>EISSN: 1998-4138</identifier><identifier>DOI: 10.4103/jcrt.JCRT_344_17</identifier><identifier>PMID: 30880774</identifier><language>eng</language><publisher>India: Wolters Kluwer India Pvt. Ltd</publisher><subject>Ablation (Surgery) ; Adenocarcinoma in Situ - mortality ; Adenocarcinoma in Situ - surgery ; Analysis ; Angiogenesis ; Animals ; Cancer metastasis ; Cancer research ; Cancer treatment ; Care and treatment ; Cell Line, Tumor - transplantation ; Chemotherapy ; Colic ; Colorectal cancer ; Colorectal Neoplasms - pathology ; Disease Models, Animal ; EDTA ; Electrodes ; Histology ; Humans ; Liver ; Liver - pathology ; Liver - surgery ; Liver cancer ; Liver Neoplasms - mortality ; Liver Neoplasms - secondary ; Liver Neoplasms - surgery ; Liver tumors ; Male ; Medical protocols ; Medical schools ; Metastasis ; Radiofrequency ablation ; Radiofrequency Ablation - adverse effects ; Radiofrequency Ablation - methods ; Rats ; Surgery ; Survival Rate ; Treatment Outcome ; Tumors ; Vascular endothelial growth factor</subject><ispartof>Journal of cancer research and therapeutics, 2019-01, Vol.15 (1), p.164-168</ispartof><rights>COPYRIGHT 2019 Medknow Publications and Media Pvt. Ltd.</rights><rights>2019. This work is published under https://creativecommons.org/licenses/by-nc-sa/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c536e-6ee858c52e064517925ce7be9c7295408cd3729aa1ebcff7ea8d6d8711ccde673</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27458,27923,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30880774$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gonganau-Nitu, Daniel</creatorcontrib><creatorcontrib>Scurtu, Radu</creatorcontrib><creatorcontrib>Precup, Calin</creatorcontrib><creatorcontrib>Ciuce, Constantin</creatorcontrib><title>An experimental protocol for in situ colorectal liver metastases ablation by radiofrequency toward a standard procedure</title><title>Journal of cancer research and therapeutics</title><addtitle>J Cancer Res Ther</addtitle><description>Background: Radiofrequency ablation (RF) is already a viable alternative to surgical resection for focal liver tumors treatment. The use of RF ablation in combination with surgery or chemotherapy and the large panel of RF tools need new experimental models to develop new opportunities for this kind of therapy. Purpose: The purpose of this study was to identify the optimal RF parameters that will allow in situ colic cancer liver metastases destruction with minimal secondary effects. Materials and Methods: The CC531s colic cancer tumor cells were used to induce liver metastases in 30 synergic Wag/Rij rats. When metastases reached at least 1 cm in diameter, RF generator RITA 1500X, and expandable tip RF probe Starburst SDE (Angiodynamics, USA) was used for the RF ablation. The animal survival rate and the RF-induced lesions have been studied, while only the generator delivered power has been modified (90W, 20W, and 10W, respectively). Results: Survival was significantly low in the group with 90W-delivered power RF. Moreover, statistically significant differences were revealed between groups with high and low RF power, regarding the morphological changes of the liver parenchyma and the adjacent organs, without significant difference on the RF therapeutically effect. Conclusions: In an experimental setting, an increased RF generator power induces important lesions of the abdominal organs with subsequently important mortality rate, without improving the RF therapeutic efficiency.</description><subject>Ablation (Surgery)</subject><subject>Adenocarcinoma in Situ - mortality</subject><subject>Adenocarcinoma in Situ - surgery</subject><subject>Analysis</subject><subject>Angiogenesis</subject><subject>Animals</subject><subject>Cancer metastasis</subject><subject>Cancer research</subject><subject>Cancer treatment</subject><subject>Care and treatment</subject><subject>Cell Line, Tumor - transplantation</subject><subject>Chemotherapy</subject><subject>Colic</subject><subject>Colorectal cancer</subject><subject>Colorectal Neoplasms - pathology</subject><subject>Disease Models, Animal</subject><subject>EDTA</subject><subject>Electrodes</subject><subject>Histology</subject><subject>Humans</subject><subject>Liver</subject><subject>Liver - pathology</subject><subject>Liver - surgery</subject><subject>Liver cancer</subject><subject>Liver Neoplasms - mortality</subject><subject>Liver Neoplasms - secondary</subject><subject>Liver Neoplasms - surgery</subject><subject>Liver tumors</subject><subject>Male</subject><subject>Medical protocols</subject><subject>Medical schools</subject><subject>Metastasis</subject><subject>Radiofrequency ablation</subject><subject>Radiofrequency Ablation - adverse effects</subject><subject>Radiofrequency Ablation - methods</subject><subject>Rats</subject><subject>Surgery</subject><subject>Survival Rate</subject><subject>Treatment Outcome</subject><subject>Tumors</subject><subject>Vascular endothelial growth factor</subject><issn>0973-1482</issn><issn>1998-4138</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp1ks2P1CAYxonRuOPq3ZMh8eKlI5S20ONksq6aTUzMeiYU3m46S2EEunX-e-nOrl8ZAwkv8HseIDwIvaZkXVHC3u90SOvP26_XklWVpPwJWtG2FUVFmXiKVqTlrKCVKM_Qixh3hNS8LMVzdMaIEITzaoXmjcPwYw9hGMElZfE--OS1t7j3AQ8OxyFNOM99AL3s2-EOAh4hqZg7RKw6q9LgHe4OOCgz-D7A9wmcPuDkZxUMVjijzixldtdgpgAv0bNe2QivHsZz9O3DxfX2Y3H15fLTdnNV6Jo1UDQAoha6LoE0VU15W9YaeAet5mVbV0Row3KlFIVO9z0HJUxjBKdUawMNZ-fo3dE3n5xvFZMch6jBWuXAT1GWtGVNSWsiMvr2H3Tnp-Dy7e4pStpasN_UjbIgB9f7FJReTOWm5kJw1lKaqeIEdQMOgrLeQT_k5b_49Qk-NwPjoE8KyFGgg48xQC_3-QtVOEhK5JINuWRD_pGNLHnz8L6pG8H8EjyGIQMXR2D2NkGIt3aaIcjM3jo__9dY0qaSGycfY8R-AvmAzz4</recordid><startdate>20190101</startdate><enddate>20190101</enddate><creator>Gonganau-Nitu, Daniel</creator><creator>Scurtu, Radu</creator><creator>Precup, Calin</creator><creator>Ciuce, Constantin</creator><general>Wolters Kluwer India Pvt. Ltd</general><general>Medknow Publications and Media Pvt. Ltd</general><general>Medknow Publications &amp; Media Pvt. Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20190101</creationdate><title>An experimental protocol for in situ colorectal liver metastases ablation by radiofrequency toward a standard procedure</title><author>Gonganau-Nitu, Daniel ; Scurtu, Radu ; Precup, Calin ; Ciuce, Constantin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c536e-6ee858c52e064517925ce7be9c7295408cd3729aa1ebcff7ea8d6d8711ccde673</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Ablation (Surgery)</topic><topic>Adenocarcinoma in Situ - mortality</topic><topic>Adenocarcinoma in Situ - surgery</topic><topic>Analysis</topic><topic>Angiogenesis</topic><topic>Animals</topic><topic>Cancer metastasis</topic><topic>Cancer research</topic><topic>Cancer treatment</topic><topic>Care and treatment</topic><topic>Cell Line, Tumor - transplantation</topic><topic>Chemotherapy</topic><topic>Colic</topic><topic>Colorectal cancer</topic><topic>Colorectal Neoplasms - pathology</topic><topic>Disease Models, Animal</topic><topic>EDTA</topic><topic>Electrodes</topic><topic>Histology</topic><topic>Humans</topic><topic>Liver</topic><topic>Liver - pathology</topic><topic>Liver - surgery</topic><topic>Liver cancer</topic><topic>Liver Neoplasms - mortality</topic><topic>Liver Neoplasms - secondary</topic><topic>Liver Neoplasms - surgery</topic><topic>Liver tumors</topic><topic>Male</topic><topic>Medical protocols</topic><topic>Medical schools</topic><topic>Metastasis</topic><topic>Radiofrequency ablation</topic><topic>Radiofrequency Ablation - adverse effects</topic><topic>Radiofrequency Ablation - methods</topic><topic>Rats</topic><topic>Surgery</topic><topic>Survival Rate</topic><topic>Treatment Outcome</topic><topic>Tumors</topic><topic>Vascular endothelial growth factor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gonganau-Nitu, Daniel</creatorcontrib><creatorcontrib>Scurtu, Radu</creatorcontrib><creatorcontrib>Precup, Calin</creatorcontrib><creatorcontrib>Ciuce, Constantin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cancer research and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gonganau-Nitu, Daniel</au><au>Scurtu, Radu</au><au>Precup, Calin</au><au>Ciuce, Constantin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An experimental protocol for in situ colorectal liver metastases ablation by radiofrequency toward a standard procedure</atitle><jtitle>Journal of cancer research and therapeutics</jtitle><addtitle>J Cancer Res Ther</addtitle><date>2019-01-01</date><risdate>2019</risdate><volume>15</volume><issue>1</issue><spage>164</spage><epage>168</epage><pages>164-168</pages><issn>0973-1482</issn><eissn>1998-4138</eissn><abstract>Background: Radiofrequency ablation (RF) is already a viable alternative to surgical resection for focal liver tumors treatment. The use of RF ablation in combination with surgery or chemotherapy and the large panel of RF tools need new experimental models to develop new opportunities for this kind of therapy. Purpose: The purpose of this study was to identify the optimal RF parameters that will allow in situ colic cancer liver metastases destruction with minimal secondary effects. Materials and Methods: The CC531s colic cancer tumor cells were used to induce liver metastases in 30 synergic Wag/Rij rats. When metastases reached at least 1 cm in diameter, RF generator RITA 1500X, and expandable tip RF probe Starburst SDE (Angiodynamics, USA) was used for the RF ablation. The animal survival rate and the RF-induced lesions have been studied, while only the generator delivered power has been modified (90W, 20W, and 10W, respectively). Results: Survival was significantly low in the group with 90W-delivered power RF. Moreover, statistically significant differences were revealed between groups with high and low RF power, regarding the morphological changes of the liver parenchyma and the adjacent organs, without significant difference on the RF therapeutically effect. Conclusions: In an experimental setting, an increased RF generator power induces important lesions of the abdominal organs with subsequently important mortality rate, without improving the RF therapeutic efficiency.</abstract><cop>India</cop><pub>Wolters Kluwer India Pvt. Ltd</pub><pmid>30880774</pmid><doi>10.4103/jcrt.JCRT_344_17</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0973-1482
ispartof Journal of cancer research and therapeutics, 2019-01, Vol.15 (1), p.164-168
issn 0973-1482
1998-4138
language eng
recordid cdi_proquest_miscellaneous_2193621508
source MEDLINE; Medknow Open Access Journals; EZB-FREE-00999 freely available EZB journals
subjects Ablation (Surgery)
Adenocarcinoma in Situ - mortality
Adenocarcinoma in Situ - surgery
Analysis
Angiogenesis
Animals
Cancer metastasis
Cancer research
Cancer treatment
Care and treatment
Cell Line, Tumor - transplantation
Chemotherapy
Colic
Colorectal cancer
Colorectal Neoplasms - pathology
Disease Models, Animal
EDTA
Electrodes
Histology
Humans
Liver
Liver - pathology
Liver - surgery
Liver cancer
Liver Neoplasms - mortality
Liver Neoplasms - secondary
Liver Neoplasms - surgery
Liver tumors
Male
Medical protocols
Medical schools
Metastasis
Radiofrequency ablation
Radiofrequency Ablation - adverse effects
Radiofrequency Ablation - methods
Rats
Surgery
Survival Rate
Treatment Outcome
Tumors
Vascular endothelial growth factor
title An experimental protocol for in situ colorectal liver metastases ablation by radiofrequency toward a standard procedure
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T13%3A25%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20experimental%20protocol%20for%20in%20situ%20colorectal%20liver%20metastases%20ablation%20by%20radiofrequency%20toward%20a%20standard%20procedure&rft.jtitle=Journal%20of%20cancer%20research%20and%20therapeutics&rft.au=Gonganau-Nitu,%20Daniel&rft.date=2019-01-01&rft.volume=15&rft.issue=1&rft.spage=164&rft.epage=168&rft.pages=164-168&rft.issn=0973-1482&rft.eissn=1998-4138&rft_id=info:doi/10.4103/jcrt.JCRT_344_17&rft_dat=%3Cgale_proqu%3EA578873911%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2193109583&rft_id=info:pmid/30880774&rft_galeid=A578873911&rfr_iscdi=true